Literature DB >> 29331794

Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen.

Wachanan Wongsena1, Lakhanawan Charoensuk2, Rungtiwa Dangtakot3, Porntip Pinlaor3, Kitti Intuyod4, Somchai Pinlaor5.   

Abstract

BACKGROUND: The combination of Opisthorchis viverrini (OV) infection and chemical carcinogen induces cholangiocarcinoma (CCA) in hamsters via inflammation-mediated mechanisms. Thus, suppression of inflammatory cells at the initial stages of CCA development would be of benefit. We aimed to investigate whether IL-17-producing CD4+ T cells (Th17) and CD4+ Foxp3+ T cells (Treg) are involved in the early stages of CCA genesis and can be targeted for suppression by melatonin.
METHODS: Inflammation, an initial stage of CCA development, was induced in hamsters by a combination of O. viverrini infection and N-nitrosodimethylamine (NDMA) administration. Melatonin (50mg/kg) was additionally administered to one group for the 30days of the experiment. Liver tissue-resident T cells were investigated using immunostaining, western blotting, and real-time PCR.
RESULTS: OV+NDMA-induced CCA tissues showed significantly higher numbers of inflammatory cells, especially eosinophils, bile duct proliferation and IL-17+ cell infiltration compared to normal livers. Expression of Foxp3 was localized in the bile duct epithelial cells, and especially in the bile duct hyperplasia. Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels. Infiltration of IL-17+ inflammatory cells and Foxp3+ cells, as well as increases in their transcription expression levels, were significantly lower in the melatonin-treated group. In contrast, increased CD4+ cell infiltration and TNF-α expression were also observed through melatonin treatment.
CONCLUSION: Melatonin exerts an immunomodulatory effect, suppressing eosinophils and Th17 cells and expression of Foxp3, but enhancing CD4+ cells and TNF-α. This suggests that melatonin may be used for CCA chemoprevention.
Copyright © 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Foxp3; IL-17+ cell; Melatonin; Opisthorchis viverrini

Mesh:

Substances:

Year:  2017        PMID: 29331794     DOI: 10.1016/j.pharep.2017.07.017

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  10 in total

Review 1.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

Review 2.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

3.  Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway.

Authors:  Fei Ma; Hu Hao; Xiaoyan Gao; Yao Cai; Jialiang Zhou; Puping Liang; Junjian Lv; Qiuming He; Congcong Shi; Dandan Hu; Bowei Chen; Lixin Zhu; Xin Xiao; Sitao Li
Journal:  Theranostics       Date:  2020-06-19       Impact factor: 11.556

Review 4.  Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs.

Authors:  Nuno Vale; Maria João Gouveia; Fátima Gärtner
Journal:  Biomolecules       Date:  2020-02-25

Review 5.  Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.

Authors:  Paula Fernández-Palanca; Carolina Méndez-Blanco; Flavia Fondevila; María J Tuñón; Russel J Reiter; José L Mauriz; Javier González-Gallego
Journal:  Antioxidants (Basel)       Date:  2021-01-12

Review 6.  Melatonin and Cancer: A Polyhedral Network Where the Source Matters.

Authors:  Maria-Angeles Bonmati-Carrion; Antonia Tomas-Loba
Journal:  Antioxidants (Basel)       Date:  2021-02-01

Review 7.  Psycho-Neuro-Endocrine-Immunology: A Role for Melatonin in This New Paradigm.

Authors:  Oscar K Bitzer-Quintero; Genaro G Ortiz; Socorro Jaramillo-Bueno; Elsy J Ramos-González; María G Márquez-Rosales; Daniela L C Delgado-Lara; Erandis D Torres-Sánchez; Aldo R Tejeda-Martínez; Javier Ramirez-Jirano
Journal:  Molecules       Date:  2022-07-30       Impact factor: 4.927

Review 8.  Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Authors:  Keisaku Sato; Fanyin Meng; Heather Francis; Nan Wu; Lixian Chen; Lindsey Kennedy; Tianhao Zhou; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  J Pineal Res       Date:  2020-03-04       Impact factor: 13.007

9.  Association of Melatonin Production with Seasonal Changes, Low Temperature, and Immuno-Responses in Hamsters.

Authors:  Xiaoying Xu; Xiaoyan Liu; Shuran Ma; Ya Xu; Ying Xu; Xiazhen Guo; Dekui Li
Journal:  Molecules       Date:  2018-03-20       Impact factor: 4.411

Review 10.  Neuroendocrine Changes in Cholangiocarcinoma Growth.

Authors:  Keisaku Sato; Heather Francis; Tianhao Zhou; Fanyin Meng; Lindsey Kennedy; Burcin Ekser; Leonardo Baiocchi; Paolo Onori; Romina Mancinelli; Eugenio Gaudio; Antonio Franchitto; Shannon Glaser; Gianfranco Alpini
Journal:  Cells       Date:  2020-02-13       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.